Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab plus docetaxel followed by FEC with or without extended trastuzumab in early breast cancer
2007-002016-26Phase 4Completed
- Sponsor
- Finnish Breast Cancer Group
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trastuzumab in breast cancer, sponsored by Finnish Breast Cancer Group. Started Jun 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002016-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002016-26.